Matthew D. Callister

1.4k total citations
20 papers, 1.0k citations indexed

About

Matthew D. Callister is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Matthew D. Callister has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Matthew D. Callister's work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Surgical Treatments (4 papers) and Colorectal and Anal Carcinomas (4 papers). Matthew D. Callister is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Surgical Treatments (4 papers) and Colorectal and Anal Carcinomas (4 papers). Matthew D. Callister collaborates with scholars based in United States. Matthew D. Callister's co-authors include Leonard L. Gunderson, Sarah Bacus, Gabriel N. Hortobágyi, Ye Ding, Christopher Knickerbocker, Susan L. Tucker, Thomas A. Buchholz, Khandan Keyomarsi, Wendy M. Toyofuku and Isabelle Bedrosian and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew D. Callister

19 papers receiving 997 citations

Peers

Matthew D. Callister
Jesse W. Keller United States
Tony Elliott United Kingdom
Antonio Cubillo Spain
Michael J. Swartz United States
Masanori Someya Japan
C. H. W. Horne United Kingdom
Jingfeng Zong China
Max M. Wattenberg United States
Marlies Michl Germany
Charles Schneider United States
Jesse W. Keller United States
Matthew D. Callister
Citations per year, relative to Matthew D. Callister Matthew D. Callister (= 1×) peers Jesse W. Keller

Countries citing papers authored by Matthew D. Callister

Since Specialization
Citations

This map shows the geographic impact of Matthew D. Callister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Callister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Callister more than expected).

Fields of papers citing papers by Matthew D. Callister

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Callister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Callister. The network helps show where Matthew D. Callister may publish in the future.

Co-authorship network of co-authors of Matthew D. Callister

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Callister. A scholar is included among the top collaborators of Matthew D. Callister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Callister. Matthew D. Callister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Gary V., Shervin M. Shirvani, Yerko Borghero, et al.. (2018). Palliation or Prolongation? The Impact of a Peer-Review Intervention on Shortening Radiotherapy Schedules for Bone Metastases. Journal of Oncology Practice. 14(8). e513–e516. 8 indexed citations
2.
Ashman, Jonathan B., Adyr A. Moss, Matthew D. Callister, et al.. (2012). Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma.. Journal of Clinical Oncology. 30(4_suppl). 327–327. 1 indexed citations
3.
Halyard, Michele Y., Angelina D. Tan, Philip J. Atherton, et al.. (2012). Assessing the clinical significance of real-time quality of life data in cancer patients treated with radiation therapy.. Journal of Clinical Oncology. 30(15_suppl). 6108–6108. 3 indexed citations
4.
Callister, Matthew D., et al.. (2011). Reduced Acute Bowel Toxicity in Patients Treated With Intensity-Modulated Radiotherapy for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(5). 1981–1987. 129 indexed citations
5.
Curtis, Kelly K., Jonathan B. Ashman, C.P. Beauchamp, et al.. (2011). Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiation Oncology. 6(1). 91–91. 25 indexed citations
6.
Hsu, Charles C., Joseph M. Herman, Michele M. Corsini, et al.. (2010). Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study. Annals of Surgical Oncology. 17(4). 981–990. 170 indexed citations
7.
Jatoi, Aminah, Gamini S. Soori, Nathan R. Foster, et al.. (2010). Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors. Journal of Thoracic Oncology. 5(12). 1994–1998. 18 indexed citations
8.
Callister, Matthew D. & Leonard L. Gunderson. (2010). Advancements in Radiation Techniques for Gastric Cancer. Journal of the National Comprehensive Cancer Network. 8(4). 428–436. 1 indexed citations
9.
Halyard, Michele Y., et al.. (2010). Assessing the clinical significance of real-time quality of life (QOL) data in cancer patients treated with radiation therapy.. Journal of Clinical Oncology. 28(15_suppl). 9107–9107. 4 indexed citations
10.
11.
Kundranda, Madappa N., Matthew D. Callister, Jonathan B. Ashman, et al.. (2010). Gemcitabine and nab-paclitaxel in patients with unresectable/borderline resectable pancreatic cancer.. Journal of Clinical Oncology. 28(15_suppl). e14675–e14675. 4 indexed citations
12.
Gunderson, Leonard L., Matthew D. Callister, Robert F. Marschke, et al.. (2008). Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status.. PubMed. 2(1). 25–33. 34 indexed citations
13.
14.
Callister, Matthew D., Gary A. Ezzell, & Leonard L. Gunderson. (2006). 2143. International Journal of Radiation Oncology*Biology*Physics. 66(3). S290–S290. 12 indexed citations
15.
Gunderson, Leonard L., Matthew D. Callister, Robert F. Marschke, et al.. (2006). Stratifying risks for patients with localized rectal cancer: Do all stage II patients require adjuvant radiation or chemoradiation?. Current Colorectal Cancer Reports. 2(3). 151–159.
16.
Keyomarsi, Khandan, Susan L. Tucker, Thomas A. Buchholz, et al.. (2002). Cyclin E and Survival in Patients with Breast Cancer. New England Journal of Medicine. 347(20). 1566–1575. 447 indexed citations
17.
Callister, Matthew D., Matthew T. Ballo, Peter W. T. Pisters, et al.. (2001). Epithelioid sarcoma: results of conservative surgery and radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 51(2). 384–391. 66 indexed citations
18.
Wang, Xiao-Fan, Lili Wang, Matthew D. Callister, et al.. (2001). Human Rad17 is phosphorylated upon DNA damage and also overexpressed in primary non-small cell lung cancer tissues.. PubMed. 61(20). 7417–21. 17 indexed citations
19.
Callister, Matthew D., Nora A. Janjan, T.D. Brown, et al.. (2000). Effective management of treatment-related enteritis during preoperative chemoradiation for locally advanced rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 48(3). 225–226. 1 indexed citations
20.
Chen, Zhong, Natalia Ortiz, Matthew D. Callister, et al.. (1998). Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.. PubMed. 58(16). 3668–76. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesse W. Keller Breakdown of academic impact, for papers by Tony Elliott Breakdown of academic impact, for papers by Antonio Cubillo Breakdown of academic impact, for papers by Michael J. Swartz Breakdown of academic impact, for papers by Masanori Someya Breakdown of academic impact, for papers by C. H. W. Horne Breakdown of academic impact, for papers by Jingfeng Zong Breakdown of academic impact, for papers by Max M. Wattenberg Breakdown of academic impact, for papers by Marlies Michl Breakdown of academic impact, for papers by Charles Schneider
Rankless by CCL
2026